fbpx

Should be a Banner 2015

Stock (Symbol) Stock Price

Celgene (CELG)

$105

Data is as of Expected to Report Sector

October 30, 2014

Jan 29

Healthcare

Sharek’s Take
David SharekCelgene is one of my top stocks for 2015. Next year, Celgene’s top-selling drug Revlimid is expanding use by getting approval for recently diagnosed multiple-myeloma patients, and this should give the company a revenue jolt. CELG has a 28 P/E on 2014 estimates, but it sells for just 22x 2015 profit estimates, even though profits are expected to climb 32% next year. This stock has huge upside in addition to certainty & consistency. I feel CELG will become more appreciated in 2015 as some of the top Internet stocks are expected to have slower profit growth, and I anticipate CELG could rise from $105 to $146 in a year.
One-Year Chart
CELG_2014_Q4This stock broke out the day it reported earnings. That’s such a good sign. And look at how profit growth is expected to escalate over the next couple of qtrs. This chart is all green.
Earnings Table
CELG_2014_Q4_EPSSales growth was 18% last quarter, and that’s usually what sales grow at. Profit growth was 24%, up from 18% 2QrtsAgo.
 
CELG only beat by 3 cents, this company isn’t big ion beating the street by a lot.
 
Annual Profit Estimates
are around what they were last quarter.
 
Quarterly profit growth is expected to accelerate next quarter, and there’s a chance profit growth could average 30% over the next four qtrs.
Fair Value
CELG_2014_Q4_PHThis stock has had an abnormally low P/E since 2012 as investors have focused on high growth names. But now I anticipate profit growth slowing with some big Internet stocks next year and that should bring more investors CELG’s way.
Ten-Year Chart
CELG_2014_Q4_10yrCELG looks to be extended, but that’s only because the stock was too low during the 2008-2011 time frame. Note profit growth has averaged 48% the per year past decade while the stock’s gone up 40% per year.
Power Ranking Bottom Line
Growth Portfolio

6 of 24

Celgene has been delivering above average profit growth for years, but I feel 2015 will prove to be a banner year for the stock as money should flow out of Internet stocks which are set to deliver slower growth.
 
Celgene is ranked 6th of 24 stocks in the Growth Portfolio Power Rankings. After “focusing my money in rapid Internet stocks in the Aggressive Growth Portfolio” last quarter, I will now purchase the stock in this portfolio as well, where it will rank 6 of 12 stocks in the Power Rankings.

Aggressive Growth Portfolio

6 of 12

Leave a Comment

Your email address will not be published. Required fields are marked *

Not a member? Sign up here for $25 a month.